期刊文献+

Mcl-1小分子抑制剂在肿瘤治疗中的应用进展 被引量:5

Research progress of small-molecule Mcl-1 inhibitors on cancer therapy
下载PDF
导出
摘要 目的阐述近年来Mcl-1小分子抑制剂的结构及在肿瘤治疗中的应用。方法归纳国内外的最新研究进展报道,按照分子结构类型,对主要的、具有发展潜力的重要分子抑制剂进行综述。结果采用计算机分子模拟、对接、活性预测,进一步通过毒性和活性测定,各种分子具有大小不等的抑制活性,并在肿瘤治疗中取得了较好的效果。结论 Mcl-1有望作为一种开发前景广阔的肿瘤治疗靶点。 Objective Mcl-1is a promising cancer target.This review highlights the current research progress on the inhibition of this target.Method Base on the inhibitors′structure,this review focuses on the current state of Mcl-1inhibitors,especially some important members.Result Aided by docking models and high-throughput screen,some inhibitors showed rather high bioactivity and low toxicity,further induced Bcl-2dependent apoptosis in some tumor cells.Conclusion The recent efforts will lead to discovery novel Mcl-1inhibitors for the treatment of cancer.
出处 《西北药学杂志》 CAS 2016年第5期547-552,共6页 Northwest Pharmaceutical Journal
基金 国家自然科学基金项目(编号:81573343)
关键词 抗凋亡蛋白 MCL-1 小分子抑制剂 anti-apoptotic proteins Mcl-1 small molecule inhibitors
  • 相关文献

参考文献35

  • 1A bulw erdi F A ,L iao C ,M ady A S - et al. 3-Substituted-N -(4-hydroxynaphthalen-1-yl) arylsulfonam idea as anel class of selective Mcl-1 inhibitors: structure-baseddesign,synthesis.,S A R , and biological evaluation [J]. JM ed C hem ,2014,57(10) : 4111-4133.
  • 2Cohen N A , Stew art M L , G avathiotii E , et al. A competitivestapled peptide screen identifies a selective smallm oleenle th at overcomes Mcl-l-dependent leukem ia cellsurvival [J]. Chem B iol, 2012,19 (9) : 1175-1186.
  • 3Lugovskoy A ,D egterev A L F ah m y A F , et al. A novelapproach for characterizing protein ligand complexes :m olecular basis for specificity of small-m olecule Bcl-2inhibitors [J]. J Am Chem S oc,200 2 , 124 (7): 12341240.
  • 4A bulw erdi F , Liao C , Liu M , et al. A novil sm all-m oleculeinhibitor of Mcl-1 blocks pancreatic cancir grow thin vitro and in Mol Cancer 丁he.r ,2014,13(3):565-575.
  • 5Chen L , W illis S N , Wei A , et al. D ifferential targetingof prosurvial Bcl-2 proteins by their BH3-only ligandsallows com plem entary apoptotic function [J]. Mol C ell,2005.17(3): 393-403.
  • 6Tanaka Y , A ikaw a K ,N.ishida G , et al. Discovery of potentMcl-l /Bcl-xL dual inhibitors by using a hybridiza tion strategy based on structural analysis of target proteins[J]. J M ed C hem , 2013 - 56(23) : 9635-9645.
  • 7V aradarajan S , V ogler M , B utterw orth M , et al. Evaluationand critical assessm ent of putative Mcl-1 inhibitors[J]. Cell D eath D iffer,2 013,20(11) : 1475-1484.
  • 8H anahan D , W einberg R A. H allm arks of cancer: thenext generation [J]. C ell,2011. 144(5) : 646-674.
  • 9R ichard D J,L e n a R , Bannister T ,e t al. H ydroxyquinoline-derived com pounds and analoguing of selective Mcl-1 inhibitors using a functional biom arker [J] . BioorgM ed C hem , 2013, 21(21) : 6642-6649.
  • 10Wei S H , Dong K , Lin F , et al. Inducing apoptosis andenhancing chem osensitivity to gem citabine via R N A interferencetargeting Mcl-1 gene in pancreatic carcinomacell [J] . Cancer C hem oth P h arm , 2008 , 62 ( 6 ) : 10551064.

同被引文献40

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部